Gallacher Capital Management LLC Pfizer Inc Transaction History

Gallacher Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $201,814 - $235,900	-6,289 Reduced 45.86%	7,424 $246 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $296,184 - $342,678	8,200 Added 148.74%	13,713 $503 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $12,919 - $16,819	328 Added 6.33%	5,513 $225 Million
Q4 2022 Jan 17, 2023	BUY	$41.75 - $54.5 $216,473 - $282,582	5,185 New	5,185 $266 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Gallacher Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gallacher Capital Management LLC with notifications on news.